Plethysmography Variability Index Monitoring for Parturients With Antepartum Hemorrhage

Continuous Non Invasive Monitoring of Both Plethysmography Variability Index and Total Hemoglobin During Cesarean Section for Antepartum Hemorrhage As a Method For Early Detection of Bleeding

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02614053

Enrollment

124

Registered

2015-11-25

Start date

2015-03-31

Completion date

2015-11-30

Last updated

2015-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antepartum Hemorrhage

Brief summary

The purpose of this study is to evaluate the use of continuous noninvasive intraoperative plethesmography variability index in conjunction with Hemoglobin levels monitoring using Masimo Radical-7™ Pulse CO-Oximeter during elective cesarean sections in patients with antepartum and intrapartum hemorrhage as a guide for fluid and blood transfusion practice .

Interventions

DEVICEMasimo Radical-7™ Pulse CO-Oximeter

a device collecting data regarding PVI, PI & spHB

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Anesthesiologist (ASA) Physical status I - II. * patients aged from 18 to 40 years * full-term multigravida parturients * antepartum hemorrhage * singleton fetus

Exclusion criteria

* Patients with known cardiac problem * peripheral circulatory failure of the upper extremities * significant liver disease * significant renal disease * significant coagulopathy

Design outcomes

Primary

Measure	Time frame
Pleth Variability Index	8 months

Secondary

Measure	Time frame
hemoglobin level	8 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026